(Q34546579)

2 August 2017

title

Management of paraneoplastic neurological syndromes: report of an EFNS Task Force (English)

1 reference

2 August 2017

1

C A Vedeler

1 reference

ORCID Public Data File 2021

2 August 2017

1 reference

author name string

J C Antoine

2

1 reference

2 August 2017

B Giometto

3

1 reference

2 August 2017

F Graus

4

1 reference

2 August 2017

W Grisold

5

1 reference

2 August 2017

I K Hart

6

1 reference

2 August 2017

J Honnorat

7

1 reference

2 August 2017

P A E Sillevis Smitt

8

1 reference

2 August 2017

J J G M Verschuuren

9

1 reference

2 August 2017

R Voltz

10

1 reference

2 August 2017

Paraneoplastic Neurological Syndrome Euronetwork

11

1 reference

2 August 2017

publication date

1 July 2006

1 reference

European Journal of Neurology

2 August 2017

published in

1 reference

2 August 2017

volume

13

1 reference

2 August 2017

issue

7

1 reference

2 August 2017

page(s)

682-690

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

2 August 2017

1 reference

Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Limbic encephalitis: comparison of FDG PET and MR imaging findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Clinical analysis of anti-Ma2-associated encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Voltage‐gated potassium channel antibodies in limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Subacute sensory neuropathy: A remote effect of carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Immunomodulatory treatment trial for paraneoplastic neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

EFNS task force--therapy of nystagmus and oscillopsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Left ventricular structure and function in obese adolescents: relations to cardiovascular fitness, percent body fat, and visceral adiposity, and effects of physical training

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Paraneoplastic Syndromes Involving the Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Antineuronal Antibodies in Patients With Neuroblastoma and Paraneoplastic Opsoclonus-Myoclonus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Screening for autoantibodies in children with opsoclonus-myoclonus-ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Autoantigen diversity in the opsoclonus-myoclonus syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Metaiodobenzylguanidine total-body scintigraphy required for revealing occult neuroblastoma in opsoclonus-myoclonus syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Phenotypic variants of autoimmune peripheral nerve hyperexcitability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Acquired neuromyotonia and peripheral neuropathy in a patient with Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Neuromyotonia, myocloni, sensory neuropathy and cerebellar symptoms in a patient with antibodies to neuronal nucleoproteins (anti-Hu-antibodies)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

Successful immunoglobulin treatment in a patient with neuromyotonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01266.X

10.1111/J.1468-1331.2006.01266.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference